Results
Bharat Parenterals Q2 PAT Jumps to ₹11.8 Crore
Bharat Parenterals reported consolidated Q2FY27 revenue of ₹136.3 crore, up 110% YoY, with PAT of ₹11.8 crore versus a loss of ₹8.6 crore last year.
Innoxel Life Sciences, a 55.9% subsidiary, was the
